A comparison between oral Dydrogestrone with intramuscular and vaginal Progesterone in frozen embryo transfer in IVF cycles.

A comparison between oral Dydrogestrone with intramuscular and vaginal Progesterone for luteal phase support in IVF , frozen embryo transfer cycles.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201406255181N15

Enrollment

Registered

2014-08-04

Start date

2014-12-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In vitro fertilization. In vitro fertilization

Interventions

Intervention group two: Luteal phase support with oral Dydrogestrone daily 40 mg from the day of 8mm endometrial thickness.

Intervention 1: Intervention group one: Luteal phase support with intramuscular Progestrone 50 mg from the day of 8mm endometrial thickness. Intervention 2: Intervention group two: Luteal phase suppo

Treatment - Drugs

Intervention group one: Luteal phase support with intramuscular Progestrone 50 mg from the day of 8mm endometrial thickness.

Intervention group three: Luteal phase support with vaginal progesterone twice daily 400 mg from the day of 8mm endometrial thickness.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria: all patients who are candidate for freeze embryo transfer

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: two weeks after embryo teransfer. Method of measurement: BHCG blood test.;Clinical pregnancy. Timepoint: Eight weeks after embryo transfer. Method of measurement: Sonography, seeing gestational sac.	—

Secondary

Measure	Time frame
Abortion. Timepoint: 2- 12 weeks after starting treatment. Method of measurement: transvaginal sonography and blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahya Ghazizadeh

School of Medicine, Tehran University of Medical Sciences

m-ghazizadeh@student.tums.ac.ir+98 21 6658 1616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026